Financial Daily from THE HINDU group of publications
Wednesday, Nov 27, 2002

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Mergers & Acquisitions


NPIL proposes merger with Global Bulk Drugs

Our Bureau

MUMBAI, Nov. 26

THE board of directors of the pharma company, Nicholas Piramal India Ltd will consider a proposal to merge Global Bulk Drugs & Fine Chemicals Pvt Ltd with itself in its meeting on November 29.

According to a press release, the proposal for merger does not envisage issue of equity capital by Nicholas Piramal (NPIL). NPIL had invested Rs 39.5 crore in preference shares of Global Bulk Drugs, which will be redeemed in cash before the merger is effected.

On receiving appropriate approvals for the merger, Nicholas Piramal's turnover on an annualised basis will go up by Rs 60 crore in the financial year 2002-03 primarily of exports, the release said.

Global Bulk Drugs has exports to the European and Canadian markets and is expected to export to the US later this year.

Send this article to Friends by E-Mail
Comment on this article to BLFeedback@thehindu.co.in

Stories in this Section
Kawasaki to source small bikes from Bajaj Auto


Reliance to hike PSF capacity
Coke, Pepsi agree to end dispute
Of green issues & luncheons
KNNL to raise Rs 125 crore through bonds
HPL may ask for extension of Nov 30 deadline
Electrolux board okays AP plant closure
Consultant named for Air India, IA revamp
Gillette to sell Geep battery business
Grasim hearing today as SEBI makes its case
SEBI argument
Lafarge still eyeing L&T's cement biz
Aztec mandates ING to scout for buy-outs
Ranbaxy chief says due diligence not properly done
NPIL proposes merger with Global Bulk Drugs
SEBI to review `takeover code'
Cabinet approves Bill on company tribunals
`Perform or perish' diktat has helped us: Indian Seamless MD
Himalaya looks to double turnover in 2 yrs
M&M bets on Bolero Sportz
Sonata pins hopes on small, medium sectors


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |

Copyright © 2002, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line